Marking its third acquisition of 2017, SinglePoint, Inc. (OTC: SING) announced on September 6 that it has acquired profitable cannabis distribution company Dr. FeelGood.
Marijuana Investing
Singlepoint, Inc. (SING) CEO Greg Lambrecht Reveals High Points of Convectium Acquisition
There should be “more funding on the way,” according to Singlepoint CEO Greg Lambrecht, who discussed the acquisition in a recent episode of MoneyTV with Donald Baillargeon.
Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Oral CBD Product to Be Tested by the University of British Columbia
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has revolutionized oral intake with its TurboCBD™ product.
Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Technology Targets Many Massive Markets
The innovative biotech has developed a lipid-based system that delivers bioactive compounds more efficiently.
India Globalization Capital, Inc. (NYSE: IGC) Preparing to Bring Cannabis Combo Therapy for Alzheimer’s Disease to Trials
India Globalization Capital, Inc. (NYSE MKT: IGC) is racing ahead with its preparation of medical trials for four drug candidates that treat a variety of debilitating conditions.
Singlepoint, Inc. (SING) Helping Cannabis Businesses Accept Transactions in a Secure and Legal Way
With this mind, it has been hard for the banking industry to support legal marijuana businesses.
India Globalization Capital, Inc. (NYSE: IGC) Provides Update on Data Linking THC to Decrease in Aβ40 Protein Production
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced compelling in vitro data compiled from genetically engineered cell lines showing that, at varying concentrations of THC, the production of Aβ40 protein decreases by as much as 50 percent over a 48-hour period.
Singlepoint, Inc. (SING) Kicks Off 2017 by Voicing Support for Congressional Push Calling for Banking Reform in the Cannabis Industry
Before the opening bell, Singlepoint, Inc. (OTC: SING) kicked off the new year by voicing its support for an ongoing congressional push calling for banking reform as it relates to the burgeoning legal cannabis industry.
Algae Dynamics Corp. (ADYNF) Collaborates with Prominent Neuroscientist to Research Cannabinoid Potential in Treating Mental Health Disorders
Algae Dynamics Corp. (OTCQB: ADYNF), a Canadian company engaged in developing proprietary research as well as products derived from cannabis and hemp oils, has commenced a collaborative relationship with Dr. Laviolette.
This Company Figured Out How to Make CBD from E. Coli
InMed Pharmaceuticals is making bacteria-bred cannabinoids “identical to those found in nature,” sans chemicals or even cannabis.
Singlepoint, Inc. (SING) CEO Discusses Cannabis Industry Game Plan in Interview with CFN Media Group
Before the opening bell, CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announced the release of an exclusive interview with Singlepoint, Inc. (OTC: SING) CEO Greg Lambrecht.
SinglePoint, Inc. (SING) Maximizes Upside Potential and Limits Downside Risk
SinglePoint, Inc. (OTC: SING), a publicly traded holding company, offers just such non-traditional upside opportunity with its foray into the burgeoning cannabis market.
At ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF), Medicinal Cannabinoid Quality and Safety are Founding Principles
Ken Clement, the founder of ABcann, with his wealth of experience and knowledge, had observed the variability in consistency and potency of cannabis that was currently available.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Builds Moat around Proprietary Biosynthesis Technology
If you have any doubt that InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is on the right track as it moves to protect its biosynthesis technology for cannabinoids, then a word from a famed figure may make you change your mind.